Target intelligence / Profile preview

Immunoglobulin heavy variable 3-76 (pseudogene) (IGHV3-76)

Target
IGHV3-76
Molecular classification
Immunoglobulin heavy variable gene family, Pseudogene
01

Overview

Immunoglobulin heavy variable 3-76 (IGHV3-76) is classified as a pseudogene, meaning it is a non-functional segment of DNA similar to a gene but does not encode a functional protein and does not participate directly in immune or pathological processes[2]. It belongs to the immunoglobulin heavy variable gene family, members of which encode the variable region of the immunoglobulin heavy chain; however, as a pseudogene, IGHV3-76 is not functionally expressed and thus is not a therapeutic target[2]. Key notes: - The gene is non-coding and non-functional, so it does not participate in antigen recognition or immune responses like functional IGHV family members[2]. - Functional IGHV genes encode for the variable region of immunoglobulin heavy chains that are involved in antigen binding and humoral immunity, but pseudogenes do not contribute to these functions[1][3]. - No drugs, biomarkers, or safety concerns are associated, as this gene does not produce a functional protein product or act in any biological process or disease role relevant to therapy. - The presence of "pseudogene" in the name and the lack of described function or disease association makes it incorrect to consider IGHV3-76 a therapeutic target[2].

Other names
3-76PIGHV376

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-76 (pseudogene) (IGHV3-76).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-76 (pseudogene) (IGHV3-76).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call